Data / Form D filings / LigoCyte Pharmaceuticals Inc
LigoCyte Pharmaceuticals Inc: Form D filings
LigoCyte Pharmaceuticals Inc, a pharmaceuticals company in Bozeman, MT, filed 5 Form D notices with the SEC between 2009 and 2012. The latest, on June 28, 2012, reports $2 million sold of a $22.1 million offering to 7 investors.
Find out what LigoCyte Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2155 Analysis Drive, Bozeman, MT, 59718
- Phone
- (406) 585-2733
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1400794
The full lists. Form D filings in Montana: 99 rows, $5, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 28, 2012 | New notice | $22,094,465 | $2,000,000 | $20,094,465 | 7 | Jun 21, 2012 | sec.gov |
| Jun 21, 2011 | New notice | $13,080,283 | $5,500,000 | $7,580,283 | 11 | Jun 7, 2011 | sec.gov |
| May 28, 2010 | Amendment | $14,661,296 | $6,572,305 | $8,088,991 | 15 | Apr 9, 2010 | sec.gov |
| Apr 22, 2010 | New notice | $14,500,000 | $6,500,000 | $8,000,000 | 11 | Apr 9, 2010 | sec.gov |
| Aug 14, 2009 | Amendment | $29,490,335 | $29,490,335 | $0 | 23 | Mar 18, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Larry Mikkola | Executive Officer | |
| Ivor Royston | Director | |
| C. Boyd Clarke | Executive Officer, Director | |
| Robert Goodwin | Executive Officer | |
| Donald Beeman | Executive Officer, Director | |
| Ben Auspitz | Director | |
| J. Donald deBethizy | Director | |
| Hironori Boyd Hozoji | Director | |
| Markus Boyd Goebel | Director |
Every Form D from the week of Jun 25, 2012 · All recent filings in Montana · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LigoCyte Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.